EUVIMEDEUVIMED entdecken
Crossref

Application of Microfluidic Devices for Automated Two‐Step Radiolabeling of Antibodies

Hiroki Jinda, Hiroyuki Watanabe iD, Kazuma Nakashima, Masahiro Ono iD

Journal of Labelled Compounds and Radiopharmaceuticals · 2024

DOI: 10.1002/jlcr.4119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2024. Verfasst von Hiroki Jinda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Isotope Labeling, Immunoconjugates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radioimmunoconjugates (RICs) composed of tumor‐targeting monoclonal antibodies and radionuclides have been developed for diagnostic and therapeutic application. A new radiolabeling method using microfluidic devices is expected to facilitate simpler and more rapid synthesis of RICs. In the microfluidic method, microfluidic chips can promote the reaction between reactants by mixing them efficiently, and pumping systems enable automated synthesis. In this study, we synthesized RICs by the pre‐labeling method, in which the radiometal is coordinated to the chelator and then the radiolabeled chelator is incorporated into the antibodies, using microfluidic devices for the first time. As a result of examining the reaction parameters including the material of mixing units, reaction temperature, and flow rate, RICs with radiochemical purity (RCP) exceeding 90% were obtained. These high‐purity RICs were successfully synthesized without any purification simply by pumping three solutions of a chelating agent, radiometal, and antibody into microfluidic devices. Under the same conditions, the RCP of RICs labeled by conventional methods was below 50%. These findings indicate the utility of microfluidic devices for automatic and rapid synthesis of high‐quality RICs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Isotope LabelingImmunoconjugatesMicrofluidic Analytical TechniquesAntibodies, MonoclonalChelating AgentsLab-On-A-Chip DevicesAutomationRadiopharmaceuticals

Stichwörter der Autor:innen

automated two‐step radiolabelingmicrofluidic deviceradioimmunoconjugate (RIC)

Substanzen

ImmunoconjugatesAntibodies, MonoclonalChelating AgentsRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.

ORCID-Profile: Hiroyuki Watanabe, Masahiro Ono

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Jinda, H., Watanabe, H., Nakashima, K., & Ono, M. (2024). Application of Microfluidic Devices for Automated Two‐Step Radiolabeling of Antibodies. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4119

Vancouver

Jinda H, Watanabe H, Nakashima K, Ono M. Application of Microfluidic Devices for Automated Two‐Step Radiolabeling of Antibodies. Journal of Labelled Compounds and Radiopharmaceuticals. 2024. doi:10.1002/jlcr.4119

BibTeX
@article{Jinda2024,
  author = {Jinda, Hiroki and Watanabe, Hiroyuki and Nakashima, Kazuma and Ono, Masahiro},
  title = {Application of Microfluidic Devices for Automated Two‐Step Radiolabeling of Antibodies},
  journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
  year = {2024},
  doi = {10.1002/jlcr.4119}
}
Kostenlos starten →